Minimum Validation Guidelines in Dna Profiling - v2010 0
Minimum Validation Guidelines in Dna Profiling - v2010 0
Aim :
One of the requirements of EN ISO/IEC 17025 is that methods used in testing laboratories should be
validated. As EN ISO/IEC 17025 only determines a general standard it is the role of the experts in a
given field to give more detailed recommendations.
The ENFSI DNA Working Group has agreed upon the minimum validation criteria as laid down in
this document. This paper can only serve as a recommendation because each DNA testing laboratory
has its own duties and workflows. There might be other approaches to validate a certain protocol or
instrument. Whatever the criteria are to validate a system, they must give evidence that the
procedures and instrument are suitable for the purpose they are used for according to EN ISO/IEC
17025. It is also an absolute necessity that the results are in concordance with the international
standards to ensure that DNA profiles are comparable between laboratories.
General prescriptions
Any change in technique (reagents, kits, apparatus ...) with a potential influence on the results,
requires an internal validation (see below).
It is essential to show that profiles obtained using the new regime are of the same, or better, quality
than those obtained under the previous regime.
Ref code: ENFSI DNA WORKING GROUP Issue No. 001 Page: 1/11
All results could be statistically evaluated.
Environmental conditions can be taken into consideration.
The validation of any new method should examine inter-operator variation.
Proficiency tests samples should be part of the validation experiments (GEDNAP, other, …).
For the validation of a specific parameter (repeatability …) at least 5 samples have to be analysed
(not including the negative control).
After running 5–10 replicate samples for a particular experiment, there are diminishing returns to
obtaining additional results. The number five is already in use throughout the forensic DNA
community1.
1
When conducting an internal validation, the SWGDAM Revised Validation Guidelines recommend running a
total of at least 50 samples—not 50 samples per experiment. (Debunking Some Urban Legends Surrounding Validation
Within the Forensic DNA Community by John Butler National Institute of Standards and Technology, Gaithersburg,
Maryland, USA – Promega, Profiles in DNA, September 2006)
Ref code: ENFSI DNA WORKING GROUP Issue No. 001 Page: 2/11
Definitions (cfr. SWGDAM revised validation guidelines)
♦ Internal validation is conducted by each forensic DNA testing laboratory and is the in-
house demonstration of the reliability and limitations of the procedure. Prior to using a
procedure for forensic applications, a laboratory must conduct internal validation studies.
♦ Sensitivity : The range of DNA quantities able to produce reliable typing results must
cover the range of DNA concentration encountered in the samples to be analysed using
the technique.
♦ Specificity: indicates to what extend the test is likely to give positive results in the case
that the tested substance is present and negative results in case of absence of the tested
substance.
♦ Repeatability : is the variation in measurements obtained when one person measures the
same unit with the same measuring equipment.
♦ Linearity : indicates the range over which the output signal strength varies in direct
proportion to the input signal.
- locus peak balance: check the peak balance of heterozygote alleles within a locus.
Acceptable inter locus peak balance ratios are > 60% for good quality samples.
- between loci peak balance : check the peak balance of alleles between all loci.
Acceptable inter loci peak balance ratios are > 60% for good quality samples.
- peak height/area: equivalent amounts of DNA should at least give equivalent peak
height/area using the new regime as the previously used regime.
Ref code: ENFSI DNA WORKING GROUP Issue No. 001 Page: 3/11
- presumptive test: is a test used to determine the biological origin of the trace sample
(blood, saliva, semen …)
Ref code: ENFSI DNA WORKING GROUP Issue No. 001 Page: 4/11
Presumptive tests
Due to the great variety of presumptive tests available, no specific indications are given in this
document. Remember that the use of these tests in your laboratory should be validated or verified as
appropriate.
Extractions
A new extraction method should be compared with the method already in use in the laboratory for
all the parameters listed below.
The validation should include the sample types normally analysed in the laboratory or any new
sample types intended to be processed with the new method.
As the DNA extraction is one of the most important steps for any downstream analysis consideration
should be given to increasing the number of tested samples to reflect the degree of modification of
the current method.
It should be verified that comparable quantities of DNA are extracted using both systems and that
DNA profiles of the same, or better, quality are obtained using the new system.
- Reproducibility : 5 replicates of the same sample (as in the repeatability test) extracted at
another time by another person.
- Different cell types (blood, semen, epithelial …) can be tested depending on the
laboratory’s common encountered samples.
Ref code: ENFSI DNA WORKING GROUP Issue No. 001 Page: 5/11
DNA Quantification
The aim of the validation of a new DNA quantification system is to establish the optimum DNA
concentration range, using the new system, to produce good quality DNA profiles.
Any commercially available and quantified human control DNA can be used to adjust a system
although any quantification results obtained can only be calculated “referring to standard DNA xxx”.
When changing quantification systems, the new system should be compared with the previous
system in order to see if amplification protocols should be modified.
- Determination of the link between quantification results and the genetic profile (no
quantification / DNA = no profile) due to a different sensitivity between quantification
and PCR multiplexes or possible inhibition.
Ref code: ENFSI DNA WORKING GROUP Issue No. 001 Page: 6/11
PCR Instruments
For a new thermal cycler model it is suggested that a number, adapted to the format of the machine,
of samples previously profiled are repeated using the kits to be used on the machine. The quality of
the resulting DNA profiles is to be equivalent or better than the profiles generated using the current
thermal cycler. The selected samples will obviously allow examination of parameters such as
reproducible results, including from mixtures and low DNA concentration samples.
For a new thermal cycler that is of the same model as others already in use, a certificate from the
manufacturer detailing a technical performance check done after installation in the laboratory and
an internal sensitivity + homogeneity check would be sufficient.
- Repeatability : the three replicates of the same sample, distributed over the entire heating
block can be used to evaluate the repeatability.
Ref code: ENFSI DNA WORKING GROUP Issue No. 001 Page: 7/11
New Multiplex Kit
If using a commercially manufactured kit there is no requirement for a developmental validation of
the kit if the validation is published or done by a collaborative exercise (e.g. by ENFSI). A
sensitivity and concordance study is recommended for samples that have previously given
acceptable profiles, especially for samples with low amounts of DNA.
- Reproducibility : 5 replicates of the same sample (as in the repeatability test) amplified at
another time by another person( --> if manually processed).
- Mixture analysis (not necessary if only reference samples are processed with this kit) : a
series of different laboratory defined mixture ratios should be tested in three replicates.
- Analysis of peak balance : check the peak balance of heterozygote alleles within a locus
and of alleles between all loci. Acceptable peak balance ratios are > 60% for good quality
samples.
- Check stutter ratios by calculating the ratio of the stutter peak height or area compared to
the corresponding allele peak height or area. In general, stutter peaks have to be lower
than the % of the allele peak height indicated by the manufacturer of the kit to be ignored
as a biological artefact of the sample.
- Concordance study : a concordance study must be have been done using PCR products
that have previously given full, balanced profiles.
- Detection of male/female components in mixtures when using specific human male DNA
amplification kits.
If deviations from the manufacturers’ protocol are introduced, these deviations should be
validated.
Ref code: ENFSI DNA WORKING GROUP Issue No. 001 Page: 8/11
Electrophoresis Equipment
The sensitivity of the new instrument should be at least as good as the sensitivity of the old
instrument and cover the PCR kit working range. The lowest concentration of DNA allowing the
operator to obtain a full genetic profile on the new instrument, under the standard laboratory
procedures, should be equal to or less than that obtained using the old instrument.
For a new capillary electrophoresis that is of the same model as others already in use a certificate
from the manufacturer about a technical performance check done after installation in the
laboratory and an internal sensitivity check would be sufficient.
- Reproducibility : 5 replicates of the same sample (as in the repeatability test) run at another
time.
- Mixture analysis : a series of lab defined mixture ratios should be tested in three replicates.
- Analysis of peak balance : check the peak balance of heterozygote alleles within a locus and of
alleles between all loci. Acceptable peak balance ratios are > 60% for good quality samples.
- Check stutter ratios by calculating the ratio of the stutter peak height or area compared to the
corresponding allele peak height or area. In general, stutter peaks have to be lower than the % of
the allele peak height indicated by the manufacturer of the kit to be ignored as a biological
artefact of the sample.
- Precision : the precision of the instrument should be such that all measured alleles fall within a
± 0.5 bp window around the measured size for the corresponding allele in the allelic ladder.
- Concordance study : a concordance study must be done using PCR products that have
previously given full, balanced profiles.
Ref code: ENFSI DNA WORKING GROUP Issue No. 001 Page: 9/11
New Software
Software eg. interpretation software sold by a company (or commercially available), should undergo
a concordance study with the previously used method. Validation data of the software should be
available from the manufacturer.
Every change in the system should be validated by a manual/visual inspection of the tested
functionality and must be documented.
Home made software (like macros or calculation sheets) should be validated.
Parameters to be validated (can vary according to the nature of the software) should consider the
following aspects :
− Sample tracking
− Data storage and alteration (traceability)
− Calculation method
Ref code: ENFSI DNA WORKING GROUP Issue No. 001 Page: 10/11
Laboratory automation
For a pipetting robot that replaces manual pipetting for a single laboratory step, e.g. PCR or CE
setup, the validation should consider the parameters listed above (see laboratory step that will be
automated), together with the following:
The performance of different robots (i.e. extraction robots) should meet the requirements defined by
the laboratory and yield enough DNA for their intended use (reference samples, crime scene
samples…).
User programmed protocols, e.g. for pipetting channels or robotic arm displacements, should be
tested with every change made to the protocol.
- Plate homogeneity.
- Cross contamination tests (i.e. droplet formation or spilling during liquid transfer).
- Traceability of sample tracking (e.g. sample dispatching protocols between source plate
(tubes) and destination plate (tubes))
- Different cell types (blood, semen, epithelial …) can be tested depending on the
laboratory’s common encountered samples.
Ref code: ENFSI DNA WORKING GROUP Issue No. 001 Page: 11/11